Clinical trial diversity data show mismatch between enrollment and disease prevalence, GSK says
A lack of diversity in clinical trials has persisted despite decades of initiatives to try to turn the tide.
In a recent …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
